Ranger Investment Management, L.P. Buys nLight Inc, Conmed Corp, LeMaitre Vascular Inc, Sells Cambrex Corp, Lantheus Holdings Inc, Tactile Systems Technology Inc

Author's Avatar
Feb 17, 2020
Article's Main Image
Dallas, TX, based Investment company Ranger Investment Management, L.P. (Current Portfolio) buys nLight Inc, Conmed Corp, LeMaitre Vascular Inc, Repligen Corp, Medpace Holdings Inc, sells Cambrex Corp, Lantheus Holdings Inc, Tactile Systems Technology Inc, Select Energy Services Inc, Quaker Chemical Corp during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Ranger Investment Management, L.P.. As of 2019Q4, Ranger Investment Management, L.P. owns 119 stocks with a total value of $1.5 billion. These are the details of the buys and sells.

For the details of Ranger Investment Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/ranger+investment+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of Ranger Investment Management, L.P.
  1. WNS (Holdings) Ltd (WNS) - 1,029,245 shares, 4.49% of the total portfolio. Shares added by 4.61%
  2. Pegasystems Inc (PEGA) - 746,611 shares, 3.92% of the total portfolio. Shares reduced by 10.47%
  3. Repligen Corp (RGEN) - 521,331 shares, 3.18% of the total portfolio. Shares added by 20.11%
  4. Inter Parfums Inc (IPAR) - 658,490 shares, 3.16% of the total portfolio. Shares added by 4.60%
  5. PRA Health Sciences Inc (PRAH) - 422,097 shares, 3.09% of the total portfolio. Shares added by 10.13%
New Purchase: nLight Inc (LASR)

Ranger Investment Management, L.P. initiated holding in nLight Inc. The purchase prices were between $13.33 and $20.64, with an estimated average price of $17.32. The stock is now traded at around $19.49. The impact to a portfolio due to this purchase was 1.05%. The holding were 784,087 shares as of .

New Purchase: American Software Inc (AMSWA)

Ranger Investment Management, L.P. initiated holding in American Software Inc. The purchase prices were between $14.63 and $16.97, with an estimated average price of $15.72. The stock is now traded at around $15.19. The impact to a portfolio due to this purchase was 0.16%. The holding were 165,181 shares as of .

New Purchase: Fulgent Genetics Inc (FLGT)

Ranger Investment Management, L.P. initiated holding in Fulgent Genetics Inc. The purchase prices were between $9.29 and $15.82, with an estimated average price of $11.9. The stock is now traded at around $18.17. The impact to a portfolio due to this purchase was 0.05%. The holding were 61,158 shares as of .

New Purchase: Catalent Inc (CTLT)

Ranger Investment Management, L.P. initiated holding in Catalent Inc. The purchase prices were between $47.06 and $56.64, with an estimated average price of $51.07. The stock is now traded at around $60.45. The impact to a portfolio due to this purchase was less than 0.01%. The holding were 46 shares as of .

Added: Conmed Corp (CNMD)

Ranger Investment Management, L.P. added to a holding in Conmed Corp by 85.03%. The purchase prices were between $93.31 and $116.55, with an estimated average price of $106.93. The stock is now traded at around $104.86. The impact to a portfolio due to this purchase was 0.72%. The holding were 212,305 shares as of .

Added: LeMaitre Vascular Inc (LMAT)

Ranger Investment Management, L.P. added to a holding in LeMaitre Vascular Inc by 44.25%. The purchase prices were between $31.27 and $36.21, with an estimated average price of $34.58. The stock is now traded at around $30.11. The impact to a portfolio due to this purchase was 0.64%. The holding were 876,366 shares as of .

Added: Repligen Corp (RGEN)

Ranger Investment Management, L.P. added to a holding in Repligen Corp by 20.11%. The purchase prices were between $73.84 and $93.08, with an estimated average price of $84.39. The stock is now traded at around $105.97. The impact to a portfolio due to this purchase was 0.53%. The holding were 521,331 shares as of .

Added: Medpace Holdings Inc (MEDP)

Ranger Investment Management, L.P. added to a holding in Medpace Holdings Inc by 39.56%. The purchase prices were between $70.08 and $84.64, with an estimated average price of $77.33. The stock is now traded at around $97.86. The impact to a portfolio due to this purchase was 0.52%. The holding were 332,565 shares as of .

Added: BJ's Restaurants Inc (BJRI)

Ranger Investment Management, L.P. added to a holding in BJ's Restaurants Inc by 47.74%. The purchase prices were between $34.55 and $43.35, with an estimated average price of $38.37. The stock is now traded at around $42.07. The impact to a portfolio due to this purchase was 0.39%. The holding were 480,118 shares as of .

Added: Endava PLC (DAVA)

Ranger Investment Management, L.P. added to a holding in Endava PLC by 21.63%. The purchase prices were between $36.65 and $48.87, with an estimated average price of $43.21. The stock is now traded at around $53.32. The impact to a portfolio due to this purchase was 0.25%. The holding were 459,857 shares as of .

Sold Out: Cambrex Corp (CBM)

Ranger Investment Management, L.P. sold out a holding in Cambrex Corp. The sale prices were between $59.46 and $59.99, with an estimated average price of $59.75.

Sold Out: ShotSpotter Inc (SSTI)

Ranger Investment Management, L.P. sold out a holding in ShotSpotter Inc. The sale prices were between $18.66 and $26.88, with an estimated average price of $22.34.

Sold Out: Medidata Solutions Inc (MDSO)

Ranger Investment Management, L.P. sold out a holding in Medidata Solutions Inc. The sale prices were between $91.48 and $92.24, with an estimated average price of $91.87.



Here is the complete portfolio of Ranger Investment Management, L.P.. Also check out:

1. Ranger Investment Management, L.P.'s Undervalued Stocks
2. Ranger Investment Management, L.P.'s Top Growth Companies, and
3. Ranger Investment Management, L.P.'s High Yield stocks
4. Stocks that Ranger Investment Management, L.P. keeps buying